Spine BioPharma
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $18M
Investors
- 4
About Spine BioPharma
Based in New York, US, and founded in 2015, Spine BioPharma, LLC, aka Spine BioPharma operates as a provider of therapeutic solutions for spine diseases. The company’s product portfolio includes SB-01 which is a therapeutic solution for degenerative disc treatment. The firm's solution has clinical advantages such as pain alleviation, function restoration, and disease progression avoidance.
Who invested in Spine BioPharma
4 investors across 2 rounds
See all investors in Spine BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Spine BioPharma
Who invested in Spine BioPharma?
Spine BioPharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spine BioPharma raised?
Spine BioPharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Spine BioPharma last raise money?
Spine BioPharma's most recent round on record is a Series B, in Mar 2022.
What does Spine BioPharma do?
Based in New York, US, and founded in 2015, Spine BioPharma, LLC, aka Spine BioPharma operates as a provider of therapeutic solutions for spine diseases.
Where is Spine BioPharma headquartered?
Spine BioPharma is headquartered in New York, US.
Which VCs invest in companies like Spine BioPharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Spine BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Spine BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.